Skip to main content
Science 37

Science 37

With nearly a decade of experience delivering hybrid and decentralized clinical trials, Science 37 brings together the end-to-end infrastructure and clinical expertise to deliver the full spectrum of remote research, while providing the flexibility to meet evolving patient and investigator needs.

With nearly a decade of experience delivering hybrid and decentralized clinical trials, Science 37 brings together the end-to-end infrastructure and clinical expertise to deliver the full spectrum of remote research, while providing the flexibility to meet evolving patient and investigator needs.

Research Excellence Across Therapeutic Areas.

A uniquely patient-friendly model makes the Science 37 Metasite™ more than a decentralized clinical trial platform. It’s an engine that drives a new breed of research by bringing clinical trials into patient homes.

This “at home” advantage fuels study innovation across therapeutic areas.

In-home spirometry for an asthma trial
At-home infusions for a postpartum depression study
Remote dermatology image capture for AI tools
Virtual SLEDAI/ESSDAI at home
25-foot walk tests at-home with an expert mobile rater
The decentralized arm for a Phase III atrial fibrillation trial

Deliver Results and Meet Clinical Trial Goals.

Science 37 accelerates patient recruitment and improves retention through expansive reach and access beyond research sites. Recent case study highlights provide a glimpse into the possibilities for your remote clinical research:

12,000

participants enrolled across 49 U.S. states in one study

2,000+

home nursing visits for an oncology study, without a single missed visit

25,000

medical records collected for a diagnostic screening study

Science 37 Delivers Results.
Clinical Trial Models That We Deliver

Clinical Trial Models That We Deliver

  • A Single, Virtual Site—The Science 37 Metasite™ delivers the end-to-end decentralized clinical trial as a single site that reaches patients regardless of location.
  • One Site of Many; Enabling Research Sites—The Science 37 Metasite™ works alongside research sites on the same trial. Sites use the Science 37 unified platform for data capture—enabling standardized data across the trial.
  • Hybrid Trials—This blend of Metasite™, Community Providers and Research Sites, allows for a portion of visits to be remote—decreasing patient burden.
Clinical Trial Models That We Deliver

Clinical Trial Models That We Deliver

  • A Single, Virtual Site—The Science 37 Metasite™ delivers the end-to-end decentralized clinical trial as a single site that reaches patients regardless of location.
  • One Site of Many; Enabling Research Sites—The Science 37 Metasite™ works alongside research sites on the same trial. Sites use the Science 37 unified platform for data capture—enabling standardized data across the trial.
  • Hybrid Trials—This blend of Metasite™, Community Providers and Research Sites, allows for a portion of visits to be remote—decreasing patient burden.

Case Studies

Case Study

Science 37 Accelerates Timelines and Expands Reach in Infectious Disease Study.

Infectious Disease
Case Study

Science 37 Decentralized Trial Model Delivers In MDD Through Centralized EnrollmentTM.

CNS
Case Study

Science 37 Supports a Hybrid Clinical Trial in Rare Neurodegenerative Disease.

CNS
Case Study

Science 37 Utilizes Flexibility of the Metasite™ Model in Study.

EDUCATION